novelty pharma gdd sa
Novelty Pharma - Innovazione farmaceutica 泡腾片
泡腾药物创新 有关公司的更多信息 25 年来，我们一直致力于开发药品和食品补充剂。我们是医疗保健领域的卓越中心，专注于药品、营养品和化妆品，我们的使命是：预见未来。得益于我们对市场趋势的持续关注，我们推动创新并创造尖端产品
- Type
- manufacturer (our classification of the record, not a statement by the company)
- Role
- Manufacturer
- Location
- Cadempino, Switzerland
- Website
- https://www.noveltypharma.com
- Categories
- 药品制造, 医疗保健用品, 补充剂与健康
Listed in a source registry
What is established and what is not
No facet of this company has been investigated yet. The facts below are collected records, not an assessment: nothing here confirms manufacturing, ownership or trading status beyond what each record literally says.
Verified facts
- domain-registered (green), checked 2026-08-02 Domain registry record
- web-presence-since (green), checked 2026-08-03 Internet Archive (Wayback)
- sanctions-clear (green), checked 2026-07-21 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
Import rules for these goods
- Food supplements sold in the EU follow Directive 2002/46/EC: most member states require a notification to the national authority before the first sale. European Commission (supplements)
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)
- Medicines imported into the EU must come from a site holding an EU GMP certificate, and the importer needs a manufacturing/import authorisation. European Medicines Agency (GMP)